Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

Vector Consumer Limited Announces Second Acquisition, Dose & Co

LONDON, May 1, 2024 /PRNewswire/ -- Vector Consumer Ltd has taken a significant stride towards expanding its presence in the collagen market with its latest acquisition, Dose & Co. This move swiftly follows another successful acquisition, the Pura Collagen brand. With the global collagen market e...

2024-05-01 17:13 1647

Vector Consumer Limited Announces Second Acquisition, Dose & Co

135th Canton Fair Showcases Leading Medical Devices, Elevating Global Health Management

GUANGZHOU, China, May 1, 2024 /PRNewswire/ -- In a significant move to meet the growing demand for health management solutions, the 135th China Import and Export Fair ("Canton Fair" or "the Fair") has brought together top-tier companies from theMedicines, Health Products and Medical Devices secto...

2024-05-01 13:40 1131

135th Canton Fair Showcases Leading Medical Devices, Elevating Global Health Management

Jacobio Pharma Announced its KRAS G12C inhibitor reached the primary endpoint

BEIJING and SHANGHAI and BOSTON, April 30, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK) announced that the data from the Phase II registrational study of the KRAS G12C inhibitor glecirasib were offically reported at the April ASCO Plenary Series, which was held online. Prof. Yuankai Shi, chief ...

2024-05-01 08:59 1047

Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers

Funding also supports the start of phase I/IIa study for lead vaccine, ITOP1 OXFORD, England, May 1, 2024 /PRNewswire/ -- Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimula...

2024-05-01 08:01 1534

Eluminex Biosciences Announces FDA Acceptance of Investigational New Drug (IND) Application for EB-105 - A Novel Trispecific Fusion Antibody for Diabetic Macular Edema (DME) - and Upcoming Scientific Presentations

SAN FRANCISCO and SUZHOU, China, April 30, 2024 /PRNewswire/ -- Eluminex Biosciences (Eluminex), a privately-held biotechnology company focused on the development of advanced protein therapeutics for vision-threatening diseases and dermal facial aesthetics announced the acceptance of their EB-105...

2024-04-30 23:00 1977

Ambpomial Active Probiotic Yogurt Shines at the European Microbiome and Probiotics Forum, Demonstrating Its Innovative Strength to the World

THE HAGUE, Netherlands, April 30, 2024 /PRNewswire/ -- The 12th Microbiome and Probiotics R&D and Business Collaboration Forum was held with great fanfare in The Hague, Netherlands from April 23rd to 24th, 2024. This prestigious conference is a leading event in the probiotics sector, drawing toget...

2024-04-30 21:09 982

Ambpomial Active Probiotic Yogurt Shines at the European Microbiome and Probiotics Forum, Demonstrating Its Innovative Strength to the World

National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) combined with R-CHOP for the treatment of diffuse large B-cell lymphoma

SHENZHEN, China, April 30, 2024 /PRNewswire/ -- Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) announced that the company's lead innovative product Chidamide (Epidaza®) , an oral subtype-selective histone deacetylase (HDAC) inhibitor, combined with R-C...

2024-04-30 20:55 1204

Marlabs welcomes Arun Mukunda as Chief Revenue Officer

Accelerates focus on Data, AI, and Digital Product Engineering (DPE) in Lifesciences, Banking, and Healthcare PISCATAWAY, N.J. and BANGALORE, India, April 30, 2024 /PRNewswire/ -- In keeping with its growth plans, the global digital solutions companyMarlabs LLC

2024-04-30 20:49 1511

A Potential First-In-Class Drug: CDE Approved Single-Arm Pivotal Clinical Study of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs

NANJING, China, April 30, 2024 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs") announced that LBL-024, an anti-PD-L1/4-1BB bispecific antibody independently developed by Leads Biolabs with global intellectual property rights has received approval to co...

2024-04-30 20:16 1180

A Potential First-In-Class Drug: CDE Approved Single-Arm Pivotal Clinical Study of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs

Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia

* The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one global alliance * Medison, the creator and leader of the multi-regional partnership category, will utilize its unique, unifiedplatform for efficient global commerciali...

2024-04-30 19:00 2382

HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business Update

* Delivered solid performance to start 2024, with record-breaking first quarter revenue of34.1 billion KRW. Strong sales momentum continued from key products, funding investments in ongoing R&D programs. * Phase 3 VELOS-4 study of tanfanercept in dry eye disease expected to be initiated in th...

2024-04-30 19:00 935

I-MAB Filed 2023 Annual Report on Form 20-F

ROCKVILLE, Md., April 30, 2024 /PRNewswire/ -- I-Mab (the "Company") (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that it has filed...

2024-04-30 19:00 2385

BiO-LiFE Herbalmeds Launches The Power of Sleep Campaign To Encourage Malaysians To Sleep Well and Stay Healthy

Herbalmeds partners with Watsons Malaysia to launch a series of sleep-focused consumer engagement activities KUALA LUMPUR, Malaysia, April 30, 2024 /PRNewswire/ -- With 9 out of 10 Malaysians experiencing some form of sleep disorder[1], getting sufficient and quality sleep has become an elusive...

2024-04-30 16:11 1232

BiO-LiFE Herbalmeds Launches The Power of Sleep Campaign To Encourage Malaysians To Sleep Well and Stay Healthy

BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report

Three-part report investigates rapid pipeline growth, partnerships, clinical trials, and patient access challenges in cancer treatment LONDON, April 30, 2024 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, explores the ...

2024-04-30 15:00 1056

Pepsodent enters Malaysia Book of Records for "Most Number of Students Brushing Teeth Simultaneously" with a total of over 6,000 students participating

KUALA LUMPUR, Malaysia, April 30, 2024 /PRNewswire/ -- Pepsodent, in collaboration with the Ministry of Health (MOH) and supported by the Ministry of Education (MOE) driven by Unilever International Malaysia, has achieved a remarkable milestone by setting anew Malaysia Book of Record for the "Mos...

2024-04-30 14:59 1271

Pepsodent enters Malaysia Book of Records for

111 to Announce First Quarter 2024 Unaudited Financial Results on May 23, 2024 - Conference Call to Follow

SHANGHAI, April 30, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced that it will report its unaudited financial result...

2024-04-30 14:30 1033

Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO)

SAN FRANCISCO and SUZHOU, China, April 30, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune,...

2024-04-30 12:30 1776

WuXi Biologics Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment

* The Company demonstrated a deep commitment to achieving ESG success in partnership with global clients, creating long-term value for all stakeholders. * The Company made remarkable progress in tackling climate change, achieving a 29% intensity reduction of Scope 1 and Scope 2 greenhouse gas ...

2024-04-30 10:55 978

Waterdrop Inc. Releases 2023 Annual Report: Sustained Profitability and Impressive Growth in Innovative Businesses

BEIJING, April 29, 2024 /PRNewswire/ -- On April 25, 2024, Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, released its annual report on Form 20-F for the fiscal year ending...

2024-04-30 10:39 2602

Australian Cosmeceutical Brand Neutriderm WINS Best Hair Hairloss Treatment in Hair Awards

SYDNEY, April 30, 2024 /PRNewswire/ -- Neutriderm, a leading Australian Cosmeceutical skin and hair care brand from UAS Pharmaceuticals, has won the Best Hair Loss Treatment for its Hair Enhancing Lotion as part of the Prevention Australia Magazine 2024 Hair Awards. The Hair Enhancing range is th...

2024-04-30 09:36 1140

123 4 5 ... 808